Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation

Table 1 Patients and treatment characteristics

No.	Age (yr)	Preoperative stage	Surgical treatment	Postoperative stage
1	56	cT3N2M0	LAR	ypT0N1M0
2	57	cT4N2M0	LAR	ypT3N0M0
3	46	cT3N2M0	LAR	ypT3N1M0
4	69	cT4N1M0	APR	ypT2N0M0
5	40	cT3N2M0	APR	ypT3N2M0
6	40	cT3N1M0	APR	ypT0N0M0
7	58	cT4N1M0	APR	ypT2N0M0
8	57	cT3N2M0	APR	ypT0N0M0
9	51	cT4N2M0	Exploratory laparotomy	ypT4N2M0
10	55	cT3N1M0	APR	ypT3N1M0
11	68	cT3N2M0	APR	ypT3N0M0
12	58	cT3N2M0	APR	ypT3N1M0
13	61	cT3N2M0	LAR	ypT1N1M0
14	32	cT4N2M0	APR	ypT3N1M0
15	55	cT3N1M0	APR	ypT3N1M0

LAR: Low anterior resection; APR: Abdominal perineal resection.